New antifungal agents

Transplant Infectious Disease

Volumn 4, Issue SUPPL. 3, 2002, Pages 52-61

  Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amphotericin; Antifungal agents; Itraconazole; Posaconazole; V echinocandin; Voriconazole

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; COLONY STIMULATING FACTOR; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; MICAFUNGIN; NIKKOMYCIN Z; NYSTATIN; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE; AMPHOTERICIN B; IMMUNOLOGICAL ADJUVANT; NEW DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; BONE MARROW TOXICITY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DESIGN; EARLY DIAGNOSIS; FUNGAL MENINGITIS; HUMAN; IMMUNOMODULATION; MYCOSIS; NEPHROTOXICITY; PANCYTOPENIA; PRESCRIPTION; PRIORITY JOURNAL; VISUAL HALLUCINATION; CLASSIFICATION; DRUG COMBINATION; REVIEW;

ADJUVANTS, IMMUNOLOGIC; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUGS, INVESTIGATIONAL; HUMANS; MYCOSES;

EID: 0036327470     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.4.s3.8.x     Document Type: Article

References (17)

1. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome
2. Prophylactic efficacy of aerosolized liposomal and non-liposomal amphotericin B in murine pulmonary aspergillosis
3. Aerosolized amphotericin B lipid complex: A novel approach to the prophylaxis of fungal infections after lung transplantation
4. Efficacy of prophylactic ABLC in a rat model of pulmonary aspergillosis
5. The impact of culture isolation of aspergillus: A hospital-based survey of aspergillosis
6. Clinical significance of nephrotoxicity in patients with amphotericin B for suspected or proven Aspergillosis
7. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
8. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
9. EORTC-IFCG phase II study on liposomal nystatin in patients with invasive aspergillus infections, refractory or intolerant to conventional/lipid ampho B
10. Multicenter, non-comparative study to evaluate safety and efficacy of caspofungin in adults with invasive aspergillosis refractory or intolerant to amphotericin B, AMC lipid formulations or azoles
11. A multicenter study of echinocandin antifungal FK463 for the treatment of esophageal candidiasis in HIV-positive patients
12. Phase II randomized open label study of two intravenous dosing regimens of v-echinocandin in the treatment of esophageal candidiasis
13. An open, non-comparative multicenter study to elevate efficacy and safety of posaconazole in the treatment of invasive fungal infections refractory or intolerant to standard therapy
14. Voriconazole for treatment of resistant and rare fungal pathogens
15. Voriconazole for the treatment of S. apiospermum and S. prolificans injection
16. Voriconazole for salvage treatment of invasive aspergillosis
17. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy of persistently febrile neutropenic patients: A randomized, international, multicenter trial